AAAAAA

   
Results: 1-7 |
Results: 7
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease
Authors: Omura-Minamisawa, M Diccianni, MB Chang, RC Batova, A Bridgeman, LJ Schiff, J Cohn, SL London, WB Yu, AL
Citation: M. Omura-minamisawa et al., p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease, CLIN CANC R, 7(11), 2001, pp. 3481-3490
Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia
Authors: Omura-Minamisawa, M Diccianni, MB Batova, A Chang, RC Bridgeman, LJ Yu, J Pullen, J Bowman, WP Yu, AL
Citation: M. Omura-minamisawa et al., Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia, CLIN CANC R, 6(4), 2000, pp. 1219-1228
Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoidsignaling and is due to a loss of sensitivity to transforming growth factor-beta
Authors: Borger, DR Mi, YD Geslani, G Zyzak, LL Batova, A Engin, TSW Pirisi, L Creek, KE
Citation: Dr. Borger et al., Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoidsignaling and is due to a loss of sensitivity to transforming growth factor-beta, VIROLOGY, 270(2), 2000, pp. 397-407
In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: A pediatric oncology group study
Authors: Omura-Minamisawa, M Diccianni, MB Batova, A Chang, RC Bridgeman, LJ Yu, J de Wit, E Kung, FH Pullen, JD Yu, AL
Citation: M. Omura-minamisawa et al., In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: A pediatric oncology group study, CANCER RES, 60(23), 2000, pp. 6573-6576
The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro
Authors: Batova, A Kamps, A Gillies, SD Reisfeld, RA Yu, AL
Citation: A. Batova et al., The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro, CLIN CANC R, 5(12), 1999, pp. 4259-4263
Methylation of p16(INK4A) in primary gynecologic malignancy
Authors: Wong, YF Chung, TKH Cheung, TH Nobori, T Yu, AL Yu, J Batova, A Lai, KWH Chang, AMZ
Citation: Yf. Wong et al., Methylation of p16(INK4A) in primary gynecologic malignancy, CANCER LETT, 136(2), 1999, pp. 231-235
Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro
Authors: Batova, A Diccianni, MB Omura-Minamisawa, M Yu, J Carrera, CJ Bridgeman, LJ Kung, FH Pullen, J Amylon, MD Yu, AL
Citation: A. Batova et al., Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro, CANCER RES, 59(7), 1999, pp. 1492-1497
Risultati: 1-7 |